immunodiagnosticsystems
0
immunodiagnosticsystems
0
  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    Hypertension
    CKD-MBD
    Growth
    Cartilage Markers
    Fertility
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • Investor Relations
  • Contact
immunodiagnosticsystems
+44 (0)191 5190660
0

Quotes

  • About IDS
    • Company Overview
    • Corporate History
    • Strategic Vision
    • Board of Directors
    • IDS Worldwide
  • Products
    Automated
    Manual
  • Instrumentation
    • IDS-iSYS Multi-Discipline Automated System
    • Specifications
    • Service & Support
  • Clinical Areas
    Bone Metabolism
    Calcium Metabolism
    Hypertension
    CKD-MBD
    Growth
    Cartilage Markers
    Fertility
  • Research Areas
    Animal Research
    Bone Turnover Markers
    Other Research Areas
  • Investor Relations
  • Contact

Month: July 2009

  • All News
  • Company News
  • Event News
  • Industry News
  • Product News
INNOVATION_GENERAL_8_K2

Annual Report and Accounts for Year Ended 31 March 2009

The Company is pleased to confirm that its Annual Report and Accounts for the year ended 31 March 2009 and Notice of the 2009 Annual General Meeting (‘AGM’) has been sent to shareholders. Copies of the 2009 Annual Report and Accounts can be found here. The AGM will be held on Friday 31st July 2009 […]

BONE_METABOLISM_K2

Launch of IDS-ISYS PINP

Immunodiagnostic Systems Holdings plc (“IDS”), a leading producer of diagnostic testing kits for the clinical and research markets, announces the launch of a newly-developed fully-automated immunoassay for PINP, used as a bone formation marker, to appear on the IDS-iSYS Immunoanalyser. IDS’s new fully-automated Immunoanalyser, the IDS-iSYS, was launched at the end of February, at the […]

  • About Us
  • Products
  • Instrumentation
  • Clinical Areas
  • Research Areas
  • Investor Relations
  • Contact
  • Disclaimer

Sign up for our Newsletter

Connect with us
Connect with us
Connect with us
  • Careers
  • News & Events
  • Sitemap
  • Cookie Policy
  • Terms of Use Policy
  • Privacy Policy
  • Acceptable Use Policy
IDS PLC © 2017 Immunodiagnostic Systems. All Rights Reserved. IDS is a listed company, traded on the Alternative Investment Market (AIM; trading symbol IDH) of the London Stock Exchange. Please note our sites uses cookies for content personalisation, please review our cookie policy for further information.

Sign up for our Newsletter

To receive our Newsletter Document Name, please provide us with your following details:

To receive our Newsletter, please provide us with your following details:

Close cookie popup

This website uses cookies: By continuing to browse this site you accept this policy.